Clinical Trials Directory

Trials / Completed

CompletedNCT06032468

ARC Intellicare for Telerehabilitation

ARC Intellicare for Telerehabilitation in Neurological Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

In the last 5 years, the available literature evidence has indicated that, in terms of clinical efficacy, telerehabilitation can give comparable results compared to face-to-face rehabilitation. Studies of post-stroke patients have revealed some benefits of telerehabilitation, such as the ability for patients to self-record pain, mood and activity. Telerehabilitation has comparable efficacy to face-to-face rehabilitation for the recovery of some abilities, such as motor function, Activities of Daily Living (ADL), and independence; it is less effective, however, for the recovery of balance control. Published reviews concerning, in particular, neurological/neurodegenerative diseases show that telerehabilitation systems are effective in maintaining and/or improving some motor aspects, such as balance and gait, and non-motor aspects, such as mood and quality of life; they also increase patient satisfaction, so in the long term they appear to be beneficial, convenient and satisfying for patients and operators. ARC Intellicare is a device undergoing certification as a Class I Medical Device (DM), already clinically tested during two uncontrolled clinical feasibility studies: ARCANGEL study (post-stroke, ClinicalTrials.gov Identifier: NCT03787433) and RICOMINCIARE study (post-COVID19 and Parkinson's disease, ClinicalTrials.gov Identifier: NCT05074771).

Conditions

Interventions

TypeNameDescription
DEVICEARC Intellicarewearable devices to guide rehabilitation exercise
OTHERRehabilitation sheetsrehabilitation exercise sheets to guide rehabilitation exercise

Timeline

Start date
2023-01-09
Primary completion
2023-09-30
Completion
2023-12-31
First posted
2023-09-13
Last updated
2024-03-13

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06032468. Inclusion in this directory is not an endorsement.